Ma Kuang Healthcare Holding Limited (TPEX:4139)
Taiwan · Delayed Price · Currency is TWD 23.75
-0.65 (-2.66%)
At close: Feb 11, 2026
TPEX:4139 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -6.05 | 10.28 | -42.53 | -30.9 | 38.54 | 77.16 |
Depreciation & Amortization | 204.43 | 212.68 | 190.7 | 160.68 | 138.1 | 134.96 |
Other Amortization | 3.65 | 3.34 | 2.21 | 1.32 | 0.77 | 0.8 |
Loss (Gain) From Sale of Assets | 2.36 | 0.36 | -0.05 | 1.16 | - | -0 |
Asset Writedown & Restructuring Costs | 11.18 | 6.66 | 7.12 | 5.88 | 5.21 | - |
Loss (Gain) on Equity Investments | - | - | - | 23.95 | - | 1.72 |
Provision & Write-off of Bad Debts | -18.33 | -39.59 | 23.56 | -2.87 | 2 | 1.45 |
Other Operating Activities | 23.53 | 40.74 | 42.94 | 14.14 | 27.87 | 45.57 |
Change in Accounts Receivable | -13.23 | 28.82 | -31.07 | -12.44 | 31.56 | 34.54 |
Change in Inventory | 2.3 | 6.69 | 53.75 | -15.61 | -23.76 | 20.52 |
Change in Accounts Payable | -12.31 | -16.05 | -31.16 | 29.62 | 0.74 | -65.34 |
Change in Unearned Revenue | -11.4 | -1.87 | 49.2 | 8.65 | 5.32 | 5.98 |
Change in Other Net Operating Assets | 70.18 | 88.07 | -65.09 | 6.31 | 5.72 | 37.32 |
Operating Cash Flow | 256.31 | 340.13 | 199.59 | 189.88 | 232.07 | 294.68 |
Operating Cash Flow Growth | -20.43% | 70.42% | 5.11% | -18.18% | -21.25% | 195.03% |
Capital Expenditures | -21.81 | -26.65 | -36.63 | -141.84 | -40.31 | -10.53 |
Sale of Property, Plant & Equipment | 0.04 | 0.83 | 0.05 | 0.83 | - | 0.24 |
Cash Acquisitions | -20.27 | - | - | -37.88 | - | 0.11 |
Sale (Purchase) of Intangibles | - | - | -11.3 | -4.06 | -0.32 | -0.09 |
Investment in Securities | - | - | 39.9 | - | 1.08 | -76.33 |
Other Investing Activities | -18.3 | 18.43 | -20.49 | 44.36 | -0.67 | -13.66 |
Investing Cash Flow | -60.33 | -7.39 | -28.47 | -138.6 | -40.22 | -100.27 |
Short-Term Debt Issued | - | - | 11.6 | 62.53 | 117.53 | 26.63 |
Long-Term Debt Issued | - | 20 | 151.74 | 369.42 | 137.57 | 186.21 |
Total Debt Issued | 167.11 | 20 | 163.34 | 431.95 | 255.1 | 212.83 |
Short-Term Debt Repaid | - | -1.58 | -2.21 | -126.68 | -36.9 | -12.82 |
Long-Term Debt Repaid | - | -346.89 | -287.34 | -358.35 | -296.08 | -282.86 |
Total Debt Repaid | -345.54 | -348.47 | -289.56 | -485.03 | -332.98 | -295.68 |
Net Debt Issued (Repaid) | -178.42 | -328.47 | -126.22 | -53.08 | -77.88 | -82.84 |
Common Dividends Paid | - | - | - | - | -68.08 | -52.87 |
Other Financing Activities | -11.9 | -38.7 | -41.6 | -25.78 | -41.75 | -21.72 |
Financing Cash Flow | -158.83 | -367.16 | -167.82 | -78.86 | -187.7 | -157.44 |
Foreign Exchange Rate Adjustments | -12.12 | 16.24 | -3.36 | 34.13 | -19.26 | -9.55 |
Net Cash Flow | 25.03 | -18.18 | -0.07 | 6.55 | -15.1 | 27.42 |
Free Cash Flow | 234.5 | 313.48 | 162.95 | 48.04 | 191.77 | 284.15 |
Free Cash Flow Growth | -20.12% | 92.37% | 239.22% | -74.95% | -32.51% | 220.17% |
Free Cash Flow Margin | 21.24% | 27.73% | 13.38% | 4.54% | 19.99% | 31.22% |
Free Cash Flow Per Share | 5.48 | 7.37 | 3.83 | 1.13 | 4.50 | 6.67 |
Cash Interest Paid | 39.6 | 44.14 | 43.26 | 26.71 | 22.38 | 21.04 |
Cash Income Tax Paid | 11.35 | 3.53 | 14.01 | 11.85 | 12.64 | 5.75 |
Levered Free Cash Flow | 206.37 | 245.97 | 122.04 | 54.23 | 200.33 | 82.03 |
Unlevered Free Cash Flow | 231.08 | 273.71 | 149.12 | 70.93 | 214.38 | 95.2 |
Change in Working Capital | 35.54 | 105.66 | -24.38 | 16.52 | 19.58 | 33.01 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.